PANOPHTHALMITIS

This adverse event was reported 183 times

These drugs are most commonly taken by patients reporting PANOPHTHALMITIS:

# Drug Count
0 TACROLIMUS 24
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 23
2 TACROLIMUS OINTMENT 0.1% 23
3 AFLIBERCEPT 15
4 DEXAMETHASONE 14
5 PREDNISONE 13
6 DEXAMETHASONE 1.5 MG 12
7 METHOTREXATE SODIUM 12
8 DOCETAXEL 11
9 DOCETAXEL ANHYDROUS 11
See all common drugs associated with PANOPHTHALMITIS

PANOPHTHALMITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PHENYLEPHRINE AND KETOROLAC 1 0.0122
1 ASPIRIN AND DIPYRIDAMOLE 1 0.0042
2 FLUORESCEIN 1 0.0016
3 DIFLUPREDNATE 5 0.0013
4 DIFLUPREDNATE OPHTHALMIC 1 0.0011
5 LATANOPROSTENE BUNOD 1 0.0009
6 METHYLPHENIDATE HCL 1 0.0008
7 MICAFUNGIN SODIUM 5 0.0008
8 FLUCYTOSINE 1 0.0007
9 POVIDONE-IODINE 3 0.0007
See all drugs enriched for association with PANOPHTHALMITIS

PANOPHTHALMITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cyclooxygenase Inhibitor [EPC] 1 0.0122
1 Diagnostic Dye [EPC] 1 0.0015
2 Nucleoside Analog Antifungal [EPC] 1 0.0007
3 Antiseptic [EPC] 3 0.0007
4 Echinocandin Antifungal [EPC] 5 0.0006
5 Lipid-based Polyene Antifungal [EPC] 6 0.0005
6 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
7 Anticholinergic [EPC] 5 0.0003
8 Rifamycin Antimycobacterial [EPC] 1 0.0003
9 Photoenhancer [EPC] 1 0.0003
See all drug classes enriched for association with PANOPHTHALMITIS